Are GLP-1 compounds safe? Not from this company and supplier, whistleblowers say

Mochi Health, a San Francisco-based weight loss startup, faces scrutiny for partnering with Aqueita Pharmacy to produce GLP-1 compounded medications. Whistleblowers allege Aqueita used unlicensed workers, allowed improper compounding practices, and shipped unsafe products with glass particles and expired drugs. The FDA warns these non-approved compounds pose risks.